Expression of Bmi-1, p14 ARF and Mdm2 and their clinical significance in colorectal carcinoma
10.13315/j.cnki.cjcep.2014.04.006
- VernacularTitle:结直肠癌中Bmi-1、p14 ARF和Mdm2的表达及临床意义
- Author:
Dongying YAO
;
Xiaoyan ZHU
- Publication Type:Journal Article
- Keywords:
colorectal neoplasms;
Bmi-1;
p14 ARF;
Mdm2;
immunohistochemistry
- From:
Chinese Journal of Clinical and Experimental Pathology
2014;(4):379-382
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To explore the expression of Bmi-1, p14ARF and Mdm2 in colorectal carcinoma and to find out their association with clinicopathological features. Methods The expression of Bmi-1, p14ARF and Mdm2 was detected by immunohistochemistry in 125 cases of colorectal carcinoma and 20 cases of normal colorectal tissues. Results ( 1 ) The positive rates of Bmi-1 and Mdm2 were 56. 8% and 62. 4% in colorectal carcinoma, respectively, which were much higher than that in normal colorectal tissues (20. 0% and 15. 0%). The positive rates of p14ARF was 47. 2% in colorectal carcinoma, which was much lower than that 75. 0% in normal colorec-tal tissues ( P<0. 05 ) . ( 2 ) The expression of Bmi-1 was significantly correlated with serosal invasion, lymph node metastasis and Dukes stage. The expression of p14ARF was significantly correlated with serosal invasion and Dukes stage. The expression of Mdm2 was significantly correlated with histologic grade, lymph node metastasis and Dukes stage (P<0. 05). (3) In colorectal carcinoma, the expression of Bmi-1 and Mdm2 was negatively correlated with p14ARF, respectively (P<0. 05). Conclusions Abnormal expression of Bmi-1, p14ARF and Mdm2 is involved in the occurrence, development and metastasis of colorectal carcinoma, which could be as the reference factors in judgement of biological behavior and provide a new target for clinical treatment.
